title: Defective functional activity and accelerated apoptosis in neutrophils from children with cancer are differentially corrected by granulocyte and granulocyte-macrophage colony stimulating factors in vitro.
abstract: We have previously shown that polymorphonuclear leucocytes (PMN) harvested from children with cancer and exposed to chemotherapy exhibit defective bactericidal activities against both Gram-positive and Gram-negative microorganisms as well as accelerated apoptosis. In this study, PMN from children with cancer were evaluated to compare in vitro the corrective effects of the two myeloid colony stimulating factors G-CSF and GM-CSF on these defective pathways. Both G-CSF and GM-CSF were able to increase the defective bactericidal activities against S. aureus and E. coli. However, GM-CSF was consistently superior to G-CSF in correcting PMN microbicidal activity; this correction was incomplete since it did not reach the level observed in normal PMN exposed to GM-CSF. The accelerated apoptosis of PMN was not affected by G-CSF. In contrast, GM-CSF significantly prolonged the survival of the PMN although it did not reach the level of survival observed with normal PMN exposed to GM-CSF. These observations were consistent with other studies indicating that in PMN, microbicidal activities and apoptosis are differentially sensitive to the myeloid growth factors G-CSF and GM-CSF.
authors.affiliation: Laboratory of Haematology, Hôpital Saint-Pierre, Brussels, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Lejeune
authors.forename: B
authors.initials: B
authors.lastname: Cantinieaux
authors.forename: S
authors.initials: S
authors.lastname: Harag
authors.forename: A
authors.initials: A
authors.lastname: Ferster
authors.forename: C
authors.initials: C
authors.lastname: Devalck
authors.forename: E
authors.initials: E
authors.lastname: Sariban
mesh_terms: D000293:Adolescent; D017209:Apoptosis; D002648:Child; D002675:Child, Preschool; D004926:Escherichia coli; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007938:Leukemia / Q000473:pathology*; D009504:Neutrophils / Q000502:physiology*; D010585:Phagocyte Bactericidal Dysfunction / Q000628:therapy*; D013211:Staphylococcus aureus
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor